Evening Technical Session

Sharing real-world experience with Fc Fusion Factors in hemophilia B: New data for rFIXFc

Monday 22 June 18:30 –19:30
Chaired by Dr Shannon Jackson
Room 717, Level 700

2015-06-22 18:30:00 2015-06-22 19:30:00 America/Toronto ISTH Evening technical session Sharing real-world experience with Fc Fusion Factors in hemophilia B: New data for rFIXFc Room 717, Level 700 Dr Shannon Jackson, ISTH 2015

Dear Colleague,
I am pleased to be able to invite you to attend our evening technical session, where we will be sharing exclusive real-world data on the use of rFIXFc for hemophilia B. The management of hemophilia B is evolving, and data from the clinic are important in supporting how we use new agents such as Fc Fusion Factors in our own practice. Join us to review the evidence and learn more about the experience to date in clinical practice.
Yours sincerely,
Shannon Jackson


18:30 Welcome and introduction Dr Shannon Jackson (Chair), Canada
18:35 New clinical data: How can it help to optimize the management of hemophilia B? Dr Shannon Jackson
18:55 Cases from the clinic – Transitioning patients in clinical practice Dr Amy Shapiro, USA
19:05 Long-acting coagulation Factors have arrived: What is the real-world experience with Factor IX Fc Fusion Factors for hemophilia B? Dr Mark Reding, USA
13:15 Future prospects for hemophilia care: Exploring the emerging science Dr Richard Blumberg, USA
19:20 Panel discussion All
19:30 Chair’s summary & close Dr Shannon Jackson


Dr Shannon Jackson (Chair)

University of British Columbia, Canada | Providence Health Care, Vancouver, Canada.

Shannon Jackson is Clinical Associateistant Professor within the Division of Hematology, St. Paul’s Hospital, at the University of British Columbia in and Staff Hematologist at Providence Health Care, Vancouver, Canada.

Dr Amy Shapiro

Indiana Hemophilia and Thrombosis Center, Indianapolis, USA | Michigan State University, East Lansing, USA

Amy Shapiro, MD, is Medical Director of the Indiana Hemophilia and Thrombosis Center in Indianapolis and Adjunct Professor of Pediatrics at Michigan State University in East Lansing. After receiving her medical training at New York University School ...

Dr Mark Reding

University of Minnesota in Minneapolis, USA

Mark T. Reding, MD, is Associate Professor of Medicine, Division of Hematology, Oncology, and Transplantation at the University of Minnesota in Minneapolis. He is also Director of the Center for Bleeding and Clotting Disorders at the University of Mi...

Thanks for visiting us


Subscribe to our newsletter for updates on this symposium and to receive any post-event materials that may be available such as slides and videos.